Aroa Biosurgery Limited (ASX:ARX)

Aroa Biosurgery Statistics

Total Valuation

Aroa Biosurgery has a market cap or net worth of AUD 231.47 million. The enterprise value is 216.89 million.

Market Cap	231.47M
Enterprise Value	216.89M

Important Dates

The last earnings date was Tuesday, January 27, 2026.

Earnings Date	Jan 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Aroa Biosurgery has 345.48 million shares outstanding. The number of shares has increased by 0.19% in one year.

Current Share Class	345.48M
Shares Outstanding	345.48M
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	25.15%
Owned by Institutions (%)	32.36%
Float	258.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	49.41
PS Ratio	2.92
PB Ratio	2.86
P/TBV Ratio	3.37
P/FCF Ratio	52.37
P/OCF Ratio	42.03
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 49.17, with an EV/FCF ratio of 49.08.

EV / Earnings	-135.93
EV / Sales	2.74
EV / EBITDA	49.17
EV / EBIT	n/a
EV / FCF	49.08

Financial Position

The company has a current ratio of 6.52, with a Debt / Equity ratio of 0.08.

Current Ratio	6.52
Quick Ratio	5.60
Debt / Equity	0.08
Debt / EBITDA	1.39
Debt / FCF	1.39
Interest Coverage	1.45

Financial Efficiency

Return on equity (ROE) is -1.97% and return on invested capital (ROIC) is 0.40%.

Return on Equity (ROE)	-1.97%
Return on Assets (ROA)	0.37%
Return on Invested Capital (ROIC)	0.40%
Return on Capital Employed (ROCE)	0.64%
Weighted Average Cost of Capital (WACC)	8.44%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.84
Inventory Turnover	1.56

Taxes

In the past 12 months, Aroa Biosurgery has paid 385,756 in taxes.

Income Tax	385,756
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.00% in the last 52 weeks. The beta is 0.78, so Aroa Biosurgery's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	+20.00%
50-Day Moving Average	0.70
200-Day Moving Average	0.63
Relative Strength Index (RSI)	47.82
Average Volume (20 Days)	141,920

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aroa Biosurgery had revenue of AUD 79.26 million and -1.60 million in losses. Loss per share was -0.00.

Revenue	79.26M
Gross Profit	67.42M
Operating Income	552,332
Pretax Income	-1.21M
Net Income	-1.60M
EBITDA	3.35M
EBIT	552,332
Loss Per Share	-0.00

Balance Sheet

The company has 20.72 million in cash and 6.15 million in debt, with a net cash position of 14.58 million or 0.04 per share.

Cash & Cash Equivalents	20.72M
Total Debt	6.15M
Net Cash	14.58M
Net Cash Per Share	0.04
Equity (Book Value)	80.98M
Book Value Per Share	0.23
Working Capital	50.49M

Cash Flow

In the last 12 months, operating cash flow was 5.51 million and capital expenditures -1.09 million, giving a free cash flow of 4.42 million.

Operating Cash Flow	5.51M
Capital Expenditures	-1.09M
Free Cash Flow	4.42M
FCF Per Share	0.01

Margins

Gross margin is 85.07%, with operating and profit margins of 0.70% and -2.01%.

Gross Margin	85.07%
Operating Margin	0.70%
Pretax Margin	-1.53%
Profit Margin	-2.01%
EBITDA Margin	4.23%
EBIT Margin	0.70%
FCF Margin	5.58%

Dividends & Yields

Aroa Biosurgery does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.19%
Shareholder Yield	-0.19%
Earnings Yield	-0.69%
FCF Yield	1.91%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Aroa Biosurgery has an Altman Z-Score of 8.68 and a Piotroski F-Score of 4.

Altman Z-Score	8.68
Piotroski F-Score	4